Eukaryotic cells respond to diverse stress signals with nuclear gene expression-designed programmes to repair cellular damage or induce apoptosis. Integration of several forms of cellular stress such as amino-acid limitation, endoplasmic reticulum (ER) stress, introduction of double-stranded RNAs into cells by viral infection and heme limitation are transduced via eIF2*α* kinases. Phospho-eIF2*α* suppresses general protein synthesis, but promotes a paradoxical increase in translation of selected mRNA species such as the activating transcription factor 4 (ATF4) (reviewed in Kilberg *et al.*^[@bib1]^). Mammalian ATF4, in turn, activates downstream transcriptional programmes designed to induce a cellular adaptation to stress. ATF4 signalling regulates a wide array of genes involved in the response to amino-acid imbalance^[@bib2],\ [@bib3]^ as well as redox enzymes.

Some autosomal recessive forms of Parkinson\'s (PD) disease are caused by mutations in *PINK1* or *PARKIN*, two genes involved in mitochondrial quality control (reviewed in Celardo *et al.*^[@bib4]^). In *Drosophila melanogaster*, mutations in either *pink1* or *parkin* cause mitochondrial dysfunction linked to the accumulation of defective organelles. Studies in this fly model showed that mitochondrial stress in *pink1* mutant results in the transcriptional activation of mitochondrial folate-mediated one-carbon metabolism genes as a protective response through an unknown mechanism.^[@bib5]^ Folate one-carbon metabolism shuttles one-carbon units for biosynthetic pathways, including nucleotide biosynthesis and methylation reactions. Enhancing one-carbon metabolism by exogenous administration of folic acid rescued mitochondrial defects in both flies and cultured human cells.^[@bib5]^ The mitochondrial one-carbon metabolism was remodelled following mitochondrial dysfunction caused by defects in the replication of mitochondrial DNA (mtDNA) in mice.^[@bib6]^

One-carbon metabolism (reviewed in Tibbetts and Appling^[@bib7]^) comprises two parallel pathways: one in the cytosol and one in mitochondria. Mitochondrial serine hydroxymethyl transferase (SHMT2) converts serine into glycine and a formyl unit attached to tetrahydrofolate (THF) that is further converted to 10-formyl-THF by NAD-dependent methylenetetrahydrofolate dehydrogenase (NMDMC), also known as mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2). 10-formyl-THF is required to make formylmethionine for mitochondrial protein synthesis.^[@bib8]^ These mitochondrial one-carbon metabolism enzymes are essential for both embryonic development^[@bib9]^ and tumourigenesis,^[@bib10]^ and both *SHMT2* and *NMDMC* are consistently upregulated in rapidly proliferating cancer cells.^[@bib11],\ [@bib12],\ [@bib13]^

We found that ATF4 controls the expression of the mitochondrial one-carbon metabolism genes *SHMT2* and *NMDMC* as a protective response to mitochondrial toxicity. *In vivo* RNAi-mediated downregulation of *Shmt2* or *Nmdmc* caused mitochondrial impairment. Conversely, their genetic enhancement suppressed neurodegeneration in both *pink1* and *parkin* mutant flies.

We conclude that mitochondrial dysfunction following disruption of the Pink1/Parkin pathway can be suppressed by the genetic enhancement of mitochondrial one-carbon metabolism. This shows that the one-carbon metabolism pathway is not only critical for the survival of proliferating cells such as cancer cells but also sustains the viability of post-mitotic cells such as neurons by promoting mitochondrial health.

Results
=======

Identification of ATF4 as an upstream regulator of one-carbon metabolism genes in *pink1* and *parkin* mutants
--------------------------------------------------------------------------------------------------------------

We have previously observed an upregulation of nucleotide metabolism pathways, including the one-carbon metabolism enzymes, in the heads of *Drosophila pink1* (*pink1*^*B9*^) mutants flies.^[@bib5]^ As Parkin cooperates with Pink1 in a pathway involved in mitochondrial quality control (QC), we compared the expression of genes involved in the mitochondrial one-carbon metabolism between *pink1* and *parkin* (*park*^*25*^) mutants. This revealed a significant increase in mitochondrial transcripts for one-carbon enzymes in the heads of both *pink1* and *parkin* mutants ([Figure 1a](#fig1){ref-type="fig"}), indicating that these transcripts are upregulated upon dysfunction of the Pink1/Parkin mitochondrial QC pathway.

To determine how mitochondrial stress in *pink1* and *parkin* mutants modulates the expression of genes involved in nucleotide metabolism, we explored the mechanism underlying transcriptional changes upon mitochondrial dysfunction. To identify the upstream regulators of altered nuclear gene expression in *pink1* or *parkin* mutants, we employed microarray technology coupled with an *in silico* approach (experimental outline, [Figure 1b](#fig1){ref-type="fig"}). We used Ingenuity upstream regulator analysis, a causal analytics algorithm designed to identify upstream regulators that are connected to data set genes.^[@bib14]^ This analysis, applied to the full complement of transcriptional changes in either *pink1* or *parkin* mutant heads, revealed a subnetwork of transcriptional changes linked to the upstream triggering of ATF4 as well as to the inhibition of the tribbles pseudokinase 3 (TRB3), a negative feedback regulator of ATF4-dependent transcription,^[@bib15]^ in both *pink1* and *parkin* mutants ([Figure 1c](#fig1){ref-type="fig"} and [Supplementary Table 1](#sup1){ref-type="supplementary-material"}). We have previously shown that mutations in *pink1* or *parkin* result in a translational shutdown^[@bib16]^ that normally coincides with an increase in ATF4 activity.^[@bib17],\ [@bib18]^ As ATF4 activation is linked to amino-acid imbalances, we next measured the endogenous amino-acid levels in *pink1* and *parkin* mutant flies. This metabolic analysis revealed an amino-acid imbalance in both *pink1* and *parkin* mutants, resulting in an increase in the majority of free amino acids (*P*\<0.001, *χ*^2^, [Figure 1d](#fig1){ref-type="fig"}).

We next assessed the protein levels of dAtf4 in *pink1* and *parkin* mutant flies. This revealed an increase in dAtf4 in both *pink1* and *parkin* adult animals ([Figure 1e](#fig1){ref-type="fig"}).

*ATF4* is required for the upregulation of *SHMT2* and *NMDMC* upon stress induction
------------------------------------------------------------------------------------

ATF4 mediates the induction of protective genes such as those involved in amino-acid metabolism and oxidative stress.^[@bib3]^ An analysis of the human orthologues of the mitochondrial one-carbon metabolism genes upregulated in *pink1* and *parkin* mutants using the 'Grow tool\' in Ingenuity Pathway Analysis (IPA) suggested that ATF4 is a direct modulator of the *SHMT2* and *NMDMC* transcripts ([Figure 2a](#fig2){ref-type="fig"}). To determine the role of *dATF4* in the regulation of *Drosophila Shmt2* and *Nmdmc*, we downregulated its expression using RNA interference (RNAi). *dATF4* RNAi resulted in a decrease in the basal transcript levels of *Shmt2* and *Nmdmc* ([Figure 2b](#fig2){ref-type="fig"}), indicating that *dATF*4 suppression is sufficient to downregulate their expression.

We next tested whether ATF4 also acts as an upstream regulator of *SHMT2* and *NMDMC* in mammalian cells. ATF4 can induce transcriptional changes after toxic insults promoted by classical ER stressors or oxidative stress.^[@bib19]^ We treated cultured mammalian cells with thapsigargin, a sarco/endoplasmic reticulum Ca^2+^ ATPase (SERCA) inhibitor, or rotenone, a mitochondrial complex I inhibitor. These treatments led to the accumulation of ATF4 ([Figures 2c and d](#fig2){ref-type="fig"}) and promoted the transcriptional upregulation of both *SHMT2* and *NMDMC*, as well as a more pronounced upregulation of *CHOP (DDIT3*), a classical ATF4 target gene, in SH-SY5Y neuroblastoma cells ([Figures 2e and f](#fig2){ref-type="fig"}). Following RNAi-mediated downregulation of *ATF4* ([Figure 2g](#fig2){ref-type="fig"}), the upregulation of both *SHMT2* and *NMDMC* in cells treated with ATF4-activating toxins was blocked ([Figures 2h and i](#fig2){ref-type="fig"}), indicating that ATF4 lies upstream of the activation of both of these one-carbon metabolism transcripts upon ER or mitochondrial stress.

Suppression of *Drosophila Shmt2* or *Nmdmc* affects development and causes mitochondrial dysfunction
-----------------------------------------------------------------------------------------------------

To investigate the *in vivo* role of *Shmt2* and *Nmdmc*, we determined the consequences of their suppression using RNAi ([Figure 3a](#fig3){ref-type="fig"}). The knockdown of *Shmt2* or *Nmdmc* caused developmental defects characterized by a significant failure of eclosion ([Figure 3b](#fig3){ref-type="fig"}). Analysis of the eclosed adults revealed that the knockdown of *Shmt2* or *Nmdmc* resulted in an impaired climbing ability, suggesting a locomotor deficit ([Figure 3c](#fig3){ref-type="fig"}), and decreased lifespan ([Figure 3d](#fig3){ref-type="fig"}). The knockdown of either *Shmt2* or *Nmdmc* led to significant metabolic changes in several canonical pathways, most significantly those related to nucleotide degradation and salvage ([Figure 3e](#fig3){ref-type="fig"} and [Supplementary Table 2](#sup1){ref-type="supplementary-material"}). To further determine whether the consequences of *Shmt2* or *Nmdmc* knockdown were linked to mitochondrial defects, we performed a morphological and functional analysis of mitochondria. This revealed a fragmented mitochondrial network ([Figures 4a and b](#fig4){ref-type="fig"}) that was associated with a loss of mitochondrial membrane potential (Δψm) in adult brain ([Figures 4c and d](#fig4){ref-type="fig"}) as well as a generalized loss of mitochondrial proteins ([Figure 4e](#fig4){ref-type="fig"}). In addition, *Nmdmc* knockdown adult flies exhibited an abnormal downturned wing posture ([Figure 4f](#fig4){ref-type="fig"}) and ultrastructural analysis of their indirect flight muscles revealed mitochondria with fragmented cristae ([Figure 4g](#fig4){ref-type="fig"}).

Taken together, these data suggest that the loss of the mitochondrial one-carbon metabolism genes *Shmt2* and *Nmdmc* results in mitochondrial dysfunction.

Suppressing the upregulation of *Shmt2* or *Nmdmc* deteriorates the PD-linked phenotypes in *pink1* and *parkin* mutants
------------------------------------------------------------------------------------------------------------------------

To confirm that transcripts for the one-carbon metabolism genes *Shmt2* and *Nmdmc* are induced in *pink1* and *parkin* mutants as a compensatory mechanism for mitochondrial dysfunction, we tested the consequences of their suppression in these mutants. As ATF4 is required for the upregulation of *SHMT2* and *NMDMC* in mammalian cells, we first determined the *in vivo* consequences of suppressing its expression in *pink1* or *parkin* mutant flies. The knockdown of *dAtf4* led to 11% and 84% lethality, respectively, in *pink1* and *parkin* mutants ([Figure 5a](#fig5){ref-type="fig"}). Analysis of the surviving *pink1* and *parkin* mutant adults with *dAtf4* knockdown confirmed the downregulation of the *dAtf4* transcript ([Figure 5b](#fig5){ref-type="fig"}) and revealed an increased penetrance of the crushed-thorax phenotype ([Figures 5c and d](#fig5){ref-type="fig"}). In addition, *dAtf4* knockdown caused a decline in the climbing performance of *pink1* mutants ([Figure 5e](#fig5){ref-type="fig"}). We next assessed the effect of *dAtf4* knockdown on the levels of *Shmt2* and *Nmdmc* in *pink1* and *parkin* mutants. This caused a moderate decrease in *Shmt2* and a more pronounced decrease in *Nmdmc* transcript levels ([Figures 5f and g](#fig5){ref-type="fig"}). Taken together, these results show that dAtf4 is involved in the upregulation of *Shmt2* and *Nmdmc* in *pink1* and *parkin* mutants. Next, we tested the effects of downregulating *Shmt2* or *Nmdmc* in *pink1* or *parkin* mutants. The knockdown of *Shmt2* or *Nmdmc* led to 100% and 99% lethality, respectively, in *parkin* mutants ([Figure 5h](#fig5){ref-type="fig"}). In *pink1* mutants, the knockdown of *Shmt2* or *Nmdmc* reduced their respective transcript levels ([Figure 5i](#fig5){ref-type="fig"}), and caused 84 and 19% lethality, respectively ([Figure 5j](#fig5){ref-type="fig"}). Analysis of the surviving adults revealed an increased penetrance of the crushed-thorax phenotype in both *Shmt2* and *Nmdmc* knockdown ([Figure 5k](#fig5){ref-type="fig"}). Furthermore, *Nmdmc* knockdown exhibited a dramatic decline in the climbing performance of *pink1* mutants ([Figure 5l](#fig5){ref-type="fig"}). These results suggest that the one-carbon metabolism genes, *Shmt2* and *Nmdmc*, were upregulated as a protective mechanism in *pink1* and *parkin* mutants.

Expression of *Shmt2* or *Nmdmc* rescues the PD-linked phenotypes in *pink1* and *parkin* mutants
-------------------------------------------------------------------------------------------------

We previously showed that the pharmacological enhancement of folic acid metabolism confers a protective effect on the mitochondria of *pink1* or *parkin* mutants.^[@bib5]^ We therefore examined the effects of overexpressing one-carbon metabolism genes, *Shmt2* and *Nmdmc*, in *pink1* or *parkin* mutants. We first confirmed the overexpression of either *Shmt2* or *Nmdmc* ([Figures 6a and b](#fig6){ref-type="fig"}) in adult flies. Next, by targeting the expression of these genes, using a neuronal driver, we rescued the mitochondrial function in neurons ([Figure 6c](#fig6){ref-type="fig"}) and the loss of dopaminergic neurons in the PPL1 cluster of both *pink1* and *parkin* mutants ([Figures 6d--f](#fig6){ref-type="fig"}). Taken together, these results show that the one-carbon metabolism genes have a neuroprotective role in the Pink1/Parkin PD model. We showed that *Shmt2* and *Nmdmc* expression is in part mediated by ATF4 in *pink1* and *parkin* mutants ([Figures 5f and g](#fig5){ref-type="fig"}). ATF4 can be activated by the ER stress-inducible kinase PERK and Gcn2, a kinase that acts as a sensor of amino-acid depletion by binding uncharged tRNAs and phosphorylating eIF2*α* on serine 51 (reviewed in Kilberg *et al.*^[@bib1]^). We showed that suppression of protein kinase R-like endoplasmic reticulum kinase (PERK) is neuroprotective in *pink1* and *parkin* mutants.^[@bib16]^ As we observed significant alterations in amino-acid levels in *pink1* and *parkin* mutants ([Figure 1d](#fig1){ref-type="fig"}), we tested whether *Drosophila Gcn2* (*dGcn2*) also plays a role in the activation of ATF4 in these mutants. RNAi-mediated suppression of *dGcn2* failed to rescue the neuronal loss in *pink1* or *parkin* mutant flies ([Figure 6g](#fig6){ref-type="fig"}). Together, these results indicate that in *pink1* and *parkin* mutants, ATF4 is regulated via PERK.

Discussion
==========

The mitochondrial retrograde response acts as a sensitive feedback system to fine-tune mitochondrial performance. We have shown that genes affecting key nucleotide metabolic processes alleviate stress through metabolic readjustments that stimulate mitochondrial function and block neurodegeneration.^[@bib5]^ Furthermore, we reported that mitochondrial dysfunction in *pink1* or *parkin* mutants activates ER stress signalling.^[@bib16]^ Here, we used an exploratory approach to determine the mechanism underlying the regulation of gene expression following mitochondrial dysfunction in the Pink1/Parkin pathway. Using a web-based analytical tool, we found evidence for the involvement of ATF4 in the activation of the mitochondrial one-carbon metabolism genes *Shmt2* and *Nmdmc* in *pink1* and *parkin* mutant flies.

We provide evidence that the one-carbon metabolism genes *Shmt2* and *Nmdmc* are under the control of ATF4. Both the ER toxin thapsigargin and the mitochondrial poison rotenone led to the ATF4-dependent activation of SHMT2 and NMDMC, most likely to alleviate stress.

Several cellular stress signals transduced through four eIF2*α* kinases led to global translation shutdown but also promoted a paradoxical increase in the translation of specific mRNAs, such as that for ATF4 (reviewed in Kilberg *et al.*^[@bib1]^). We have reported that mitochondrial stress in *pink1* or *parkin* mutant flies results in global translational shutdown via PERK, an eIF2*α* kinase, with neurotoxic consequences.^[@bib16]^ In spite of the global translational shutdown, transcripts for *Shtm2* and *Nmdmc* are upregulated in *pink1* and *parkin* mutants ([Figures 5f and g](#fig5){ref-type="fig"} and Tufi *et al.*^[@bib5]^), and here we report that their overexpression via ATF4 is neuroprotective. This illustrates another paradox linked to the activation of PERK. How can PERK signalling cause translational shutdown with a neurotoxic outcome whereas via ATF4 it promotes the activation of neuroprotective genes? We propose that this could result from a compromised biphasic response to PERK activation in neurons. The short-term PERK-dependent translational shutdown in cells is followed by a recovery of translation via GADD34-dependent dephosphorylation of eIF2*α* (reviewed in Kilberg *et al.*^[@bib1]^). However, the sustained phosphorylation of eIF2*α* in neurons of *pink1* or *parkin* mutants might not be able to sustain an efficient translation of ATF4 targets even though their mRNA pools are increased.

Eukaryotic one-carbon metabolism comprises parallel cytosolic and mitochondrial pathways connected by the one-carbon donors serine, glycine and formate. We show here that compromising the mitochondrial one-carbon pathway by downregulating *Shmt2* or *Nmdmc* leads to significant changes in nucleotide pathways. *Shmt2* or *Nmdmc* silencing resulted in mitochondrial dysfunction and led to both developmental defects and decreased viability of adult flies. This result suggests that mitochondrial one-carbon metabolism is important for the normal function of these organelles. *pink1* or *parkin* mutants show a significant upregulation of transcripts for *Shmt2* and *Nmdmc* ([Figures 5f, g and i](#fig5){ref-type="fig"}). We propose that the enhanced *Shmt2* and *Nmdmc* transcripts levels represents a compensatory attempt to revert the mitochondrial dysfunction caused by defects in the Pink1/Parkin pathway, as the rescue of neurodegeneration in either *pink1* or *parkin* mutants can be achieved by the overexpression of either *Shmt2* or *Nmdmc*. If both *Shmt2* and *Nmdmc* are already upregulated in *pink1* or *parkin* mutants, why then do we need to artificially enhance their expression to achieve neuroprotection in these flies? It is conceivable that even if their transcription is increased, their protein levels remain at basal levels because of the sustained inhibition of translation present in *pink1* or *parkin* mutants.^[@bib16]^ Currently, this cannot be confirmed as we do not have reagents capable of detecting endogenous levels of Shmt2 or Nmdmc in flies.

We conclude that mitochondrial dysfunction caused by the loss of *pink1* and *parkin* in flies engages dATF4-dependent protective mechanisms. Post-mitotic cells such as neurons are reported to lack the *de novo* nucleotide biosynthetic pathways and rely instead on the salvage pathway;^[@bib20]^ however, both Shmt2 and Nmdmc are components of one-carbon metabolism involved in the *de novo* biosynthetic pathway. Therefore, our observation that the overexpression of either of these genes can suppress neurodegeneration in fly models of PDs challenges the notion that *de novo* nucleotide biosynthetic pathways are irrelevant in postmitotic cells such as neurons.

In conclusion, we propose mitochondrial one-carbon metabolism is critical in at least two separate settings: it not only ensures the accurate nuclear DNA replication in proliferating cells such as cancer or embryonic cells but also counteracts mitochondrial dysfunction in post-mitotic cells such as neurons.

Materials and methods
=====================

Genetics and *Drosophila* strains
---------------------------------

Fly stocks and crosses were maintained on standard cornmeal agar media at 25 °C. The strains used were *pink1*^*B9*^, *park*^*25*^ and *daGAL4* (kind gifts from A Whitworth, MRC, Centre for Developmental and Biomedical Genetics, University of Sheffield, Sheffield, UK), *w*^*1118*^, *elavGAL4* (Bloomington Stock Centre, Bloomington, IN, USA) and RNAi lines: *Shmt2* (RNAi\#1, ID: 19206; RNAi\#2, ID: 19208), *Nmdmc* (RNAi\#1, ID: 5706; RNAi\#2, ID: 110198), *dAtf4* (RNAi\#1, ID: 2935; RNAi\#2, ID: 109014) and *dGcn2* (ID: 103976) (Vienna Drosophila RNAi Centre, Vienna, Austria). UAS *dAtf4* was from Zurich ORFeome Project (Zurich, Switzerland) (ID: F000106). HA-tagged cDNA fragments encoding full-length *Shmt2* (ID: RH67089) and *Nmdmc* (ID: GH01066) from Drosophila Genomics Resource Center (Bloomington, IN, USA) were cloned into *pUASTattB* vector for PhiC31-mediated site-directed transgenesis. Transgenic flies were generated at the Cambridge fly facility, Department of Genetics, University of Cambridge (Cambridge, UK). All the experiments on adult flies were performed with males.

Metabolic profiling
-------------------

Global metabolic profiles were obtained from 3-day-old flies using the Metabolon Platform (Metabolon Inc., Morrisville, NC, USA) as previously described.^[@bib5]^ Essentially, each sample consisted of 8 biological replicates (100 flies per replicate). The sample preparation process was carried out using the automated MicroLab STAR system from Hamilton Company (Bonaduz, GR, Switzerland). For sample extraction, 80% (v/v) methanol/water solution was used. Samples were then prepared for the appropriate instrument, either LC/MS or GC/MS. Compounds above the detection threshold were identified by comparison with library entries of purified standards or recurrent unknown entities. Identification of known chemical entities was based on comparison with metabolomic library entries of purified standards.

Microarray acquisition and analysis
-----------------------------------

RNA was prepared from the heads of male adult flies (6 samples in total, 3 replicates for each genotype). The RNA quality was confirmed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Detailed experimental protocols and raw data were deposited in ArrayExpress under accession E-MTAB-1406. Differential expression was analysed using the Partek Genomics Suite (Partek Inc., St. Louis, Missouri, USA).

Pathway analysis
----------------

Data were processed using the Ingenuity Pathway Analysis (IPA), build 313398M, content version 18841524 (QIAGEN, Hilden, Germany). To determine the putative modulators of the observed expression changes in *pink1*^*B9*^ and *park*^*25*^ mutant flies, we employed the IPA Comparison Analysis using the Upstream Regulator analytic sub-routine. This programme computes two statistical measures for each potential transcriptional regulator (TR): an overlap *P*-value and an activation *z*-score. The overlap *P-*value calls likely upstream regulators based on significant overlap between data set genes and known targets regulated by a TR. The activation *z*-score is used to infer likely activation states of upstream regulators based on comparison with a model that assigns random regulation directions.^[@bib14]^ In practice, *z*-scores greater than 2 or smaller than −2 can be considered significant. For the identification of coordinate changes in metabolite abundance in *Shmt2* and *Nmdmc* RNAi strains, we employed the IPA Comparison Analysis workflow. This programme computes a *P*-value (Fisher\'s exact test) based on significant overlap between the observed metabolic changes and known canonical pathways defined by the HumanCyc metabolic pathway information data set (QIAGEN).

Cell culture and transfections
------------------------------

SH-SY5Y were cultured in DMEM/F12 1:1 (Gibco BRL, Waltham, MA, USA) supplemented with 10% heat-inactivated FCS (Invitrogen, Waltham, MA, USA), 100 U/ml penicillin (Gibco BRL) and 100 *μ*g/ml streptomycin (Gibco BRL). The cells were maintained at 37 °C in 5% CO~2~ in culture medium. RNA silencing was performed by delivering siRNA at a concentration of 10 nM into SH-SY5Y cells. Lipofectamine RNAiMAX (Invitrogen) was used as the transfection reagent. The siRNA was obtained from Dharmacon (Lafayette, CO, USA) (ON-TARGETplus Non-targeting Pool, \#D-001810-10-05; ATF4, SMARTpool: ON-TARGETplus L-005125-00-0005).

Protein extraction and western blotting
---------------------------------------

Protein extracts from whole flies were prepared by grinding flies in lysis buffer (100 mM KCl, 20 mM Hepes at pH 7.5, 5% (v/v) glycerol, 10 mM EDTA, 0.1% (v/v) Triton X-100, 10 mM DTT, 1 *μ*g/ml leupeptin, 1 *μ*g/ml antipain, 1 *μ*g/ml chymostatin and 1 *μ*g/ml pepstatin). Protein extracts from cells were prepared by scraping them in lysis buffer (20 mM Tris at pH 7.5, 150 mM NaCl, 1% (v/v) Nonidet-40, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS) containing phosphatase inhibitor cocktail tablets PhosSTOP (Roche, Basel, Switzerland) and the protease inhibitors leupeptin, antipain, chymostatin and pepstatin (Sigma, Dorset, UK) at the manufacturer\'s recommended dilution. The suspensions were cleared by centrifugation at 21 000 × *g* for 10 min at 4 °C and protein concentrations of the supernatants were measured using the Bradford assay (Bio-Rad, Hercules, CA, USA). For the dATF4 immunoblot, protein extracts from whole flies were prepared by grinding flies in the same buffer as those for protein extraction from cells. All supernatants were mixed with 4 × LDS loading buffer. For SDS-PAGE, equivalent amounts of proteins were resolved on 4--12% or 10% Precast Gels (Invitrogen) and transferred onto PVDF membranes (Millipore, Watford, UK). The membranes were blocked in TBS (0.15 M NaCl and 10 mM Tris-HCl, pH 7.5) containing 10% (w/v) dried non-fat milk for 1 h at room temperature, probed with the indicated primary antibody before being incubated with the appropriate HRP-conjugated secondary antibody. Antibody complexes were visualized by Pierce (Waltham, MA, USA) enhanced chemiluminescence (ECL).

Antibodies
----------

Primary antibodies employed in this study were *α*-tubulin (Sigma, T6074), HA (Roche Applied, Basel, Switzerland, 11583816001), ATF4 to probe human cell samples (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-22800), dATF4 to probe *Drosophila* samples (a kind gift from Min Kang, University of Ulsan, Seoul, South Korea), GAPDH (Sigma, G8795), NDUFS3/complex I (Abcam, Cambridge, UK, ab14711), mtCO1 (Abcam, ab90668), *α*-tubulin (Sigma, T6074) and TH (Immunostar, Hudson, WI, USA, 22941).

RNA extraction and quantitative real-time RT-PCR
------------------------------------------------

Total RNA was extracted using the RNeasy Mini Kit (QIAGEN; for mammalian cells) or TRIzol (Ambion, Waltham, MA, USA; for *Drosophila* tissues) and quantified by spectrophotometric analysis. Quantitative real-time PCR with reverse transcription (qRT--PCR) was performed on a real-time cycler (Applied Biosystems, Foster City, CA, USA, 7500 Fast Real-Time PCR Systems) using the SensiFAST SYBR Lo-ROX one-Step Kit (Bioline, London, UK). Gene-specific primers were obtained from QIAGEN (QuantiTect Primer Assays) for the following genes: *DDIT3* (QT00082278), *dATF4* (QT00503069), *CG3999* (QT00972349), *CG6415* (QT00934318), *Nmdmc* (dm: QT00503153, hs: QT00081592), *Parkin* (QT00023401), *Pink1* (QT01670459) and *Shmt2* (dm: QT00498904, hs: QT00012754). Gene-specific primers obtained from Sigma were: *hsATF4* (forward, 5′-CCCTTCACCTTCTTACAACCTC-3′ reverse, 5′-GTCTGGCTTCCTATCTCCTTCA-3′), *rp49* (forward, 5′-TGTCCTTCCAGCTTCAAGATGACCATC-3′ reverse, 5′-CTTGGGCTTGCGCCATTTGTG-3′), *TBP* (forward, 5′-TCAAACCCAGAATTGTTCTCCTTAT-3′ reverse, 5′-CCTGAATCCCTTTAGAATAGGGTAGA-3′). *rp49* and *TBP* were used as housekeeping genes when analysing fly and cells samples, respectively.

Immunofluorescence and confocal microscopy
------------------------------------------

To analyse the mitochondria in larvae brains and ventral nerve cord nerves, tissues from third-instar larvae were dissected in PBS, transferred to a drop of PBS as mounting medium on glass slides, covered with coverslip and imaged on a Zeiss (Cambridge, UK) LSM510 confocal microscope.

Lifespan analysis
-----------------

Groups of 15 newly eclosed males of each genotype were placed into separate vials with food and maintained at 25 °C. The flies were transferred into vials containing fresh food every 2 to 3 days, and the number of dead flies was recorded. The data are presented as Kaplan--Meier survival distributions, and the significance was determined by log-rank tests.

Climbing assay
--------------

The climbing assays were performed as previously described^[@bib21]^ using a countercurrent apparatus. A total of 15 to 20 male flies were placed into the first chamber, tapped to the bottom and then given 20 s to climb a distance of 10 cm. Those flies that successfully climbed 10 cm or beyond in 20 s were then shifted to a new chamber, and both sets of flies were given another opportunity to climb the 10 cm distance. This procedure was repeated a total of five times. After five trials, the number of flies in each chamber was counted. A video demonstrating the technique can be found at <https://youtu.be/vmR6s_WAXgc>. The climbing index was measured by using a weighted average approach using the following formula:

In this formula, *n*0 corresponds to the flies that fail the first trial and *n*1 to *n*5 the number of flies that successfully pass each respective trial. At least 100 flies were used for each genotype tested.

*Drosophila* phenotypic analysis
--------------------------------

To quantify the eclosion defects, adult parent flies were removed 3 to 4 days after the setup of crosses. Eclosion of progeny was monitored for 10 days after the first fly had hatched. The total numbers of empty and full pupae cases were counted and used for statistical analysis.

To quantify lethality, the number of both male and female *park*^*25*^ homozygotes to total flies (*park*^*25*^homozygotes+heterozygotes) and the number of *pink1*^*B9*^ to total males (*pink1*^*B9*^+*FM6*) were counted and used for statistical analysis.

To assess downturned wing phenotype, groups of ten 3-day-old male flies were acclimatized for at least 1 h in fresh vials. The number of flies that presented with downturned wings was counted. Counts were repeated three times to confirm the result. The total number of flies with or without downturned wings were counted and used for statistical analysis.

Microscopy-based assessment of mitochondrial function and morphology
--------------------------------------------------------------------

Measurements of Δψm in fly brains were performed as previously described.^[@bib5]^ Briefly, fly brains were loaded for 40 min at room temperature with 40 nM TMRM in loading buffer (10 mM HEPES pH 7.35, 156 mM NaCl, 3 mM KCl, 2 mM MgSO~4~, 1.25 mM KH~2~PO~4~, 2 mM CaCl~2~, 10 mM glucose) and the dye was present during the experiment. In these experiments, TMRM is used in the redistribution mode to assess Δψm, and therefore a reduction in TMRM fluorescence represents mitochondrial depolarization. Confocal images were obtained using a Zeiss 510 confocal microscope equipped with a 40 × oil immersion objective. Illumination intensity was kept to a minimum (at 0.1--0.2% of laser output) to avoid phototoxicity and the pinhole was set to give an optical slice of 2 *μ*m. Fluorescence was quantified by exciting TMRM using the 565 nm laser and measured above 580 nm. *Z*-stacks of 5 fields of 300 *μ*m^2^ each per brain were acquired, and the mean maximal fluorescence intensity was measured for each group. Mitochondrial length was calculated as previously described^[@bib22]^ by using the 'ruler\' and 'measurement\' tools in Photoshop CS3 Extended (San Jose, CA, USA) to measure the length of mitoGFP-positive mitochondria across their largest dimension.

Electron microscopy
-------------------

For transmission electron microscopy (TEM), adult fly thoraces were fixed overnight in 0.1 M sodium cacodylate buffer (pH 7.4) containing 2% paraformaldehyde, 2.5% glutaraldehyde and 0.1% Tween-20. Samples were post-fixed for 1 h at room temperature in a solution containing 1% osmium tetroxide and 1% potassium ferrocyanide. After fixation, samples were stained *en bloc* with 5% aqueous uranyl acetate overnight at room temperature; the samples were then dehydrated via a series of ethanol washes and embedded in TAAB epoxy resin (TAAB Laboratories Equipment Ltd, Aldermaston, UK). Semi-thin sections were stained with toluidine blue, and areas of the sections were selected for ultramicrotomy. Ultrathin sections were stained with lead citrate and imaged using a MegaView 3 digital camera and iTEM software (Olympus Soft Imaging Solutions GmbH, Münster, Germany) in a Jeol 100-CXII electron microscope (Jeol UK Ltd, Welwyn Garden City, UK).

Analysis of dopaminergic neurons
--------------------------------

Fly brains were dissected from 20-day-old flies and stained for anti-tyrosine hydroxylase (Immunostar) as previously described.^[@bib23]^ Brains were positioned in PBS+0.1% Triton in a coverslip clamp chamber (ALA Scientific Instruments Inc., Farmingdale, NY, USA) using a harp made of platinum wire and nylon string and imaged by confocal microscopy. Tyrosine hydroxylase-positive PPL1 cluster neurons were counted per brain hemisphere. Data acquired for the assessment of each genotype were obtained as a single experimental set before statistical analysis.

Statistical analyses
--------------------

Descriptive and inferential statistical analyses were performed using GraphPad Prism 6 ([www.graphpad.com](http://www.graphpad.com)). Computation of the minimal sample size for the variables measured in this study was assessed by power analysis, setting alpha initially to 0.05, using StatMate 2 ([www.graphpad.com](http://www.graphpad.com)).

Data are presented as the mean values, and the error bars indicate±S.D. The number of biological replicates per experimental variable (*n*) is indicated in either the figures or figure legends. Parametric tests were used (performed using data obtained from pilot experiments) after confirming that the variables under analysis displayed Gaussian distributions using the D\'Agostino-Pearson test (computed using GraphPad Prism 5). The significance is indicated as \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 and \*\*\*\**P*\<0.0001. For the statistical analysis of metabolites in flies, pair-wise comparisons were performed using Welch\'s *t*-tests. The *q*-value provides an estimate of the false discovery rate (FDR) according to Storey and Tibshirani.^[@bib24]^ The investigators gathering quantitative data on biological samples were not blinded to the sample identities at the time of analysis. No specific randomization strategies were employed when assigning biological replicates to treatment groups.

Digital image processing
------------------------

Fluorescence, transmission electron microscope and western blot images were acquired as uncompressed bitmapped digital data (TIFF format) and processed using Adobe Photoshop, employing established scientific imaging workflows.^[@bib25]^
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![*In silico* identification of ATF4 as a regulator of transcriptional changes in *pink1* and *parkin* mutants. (**a**) Enhanced expression of one-carbon metabolism genes *Shmt2*, *Nmdmc*, *CG3999* (GCS P protein, glycine dehydrogenase) and *CG6415* (GCS T protein, aminomethyl transferase) in heads of 3-day-old *pink1* or *parkin* mutant flies. Relative levels to the *w*^*1118*^ control flies are indicated. Red corresponds to transcripts that are upregulated to a significant (*P*⩽0.05) level. Significance was determined using a two-tailed unpaired *t*-test (3 to 8 biological replicates per sample). (**b**) Workflow employed for the identification of upstream regulators of transcriptional changes upon loss of *pink1* or *parkin*. (**c**) Analysis of upstream modulators of gene expression changes observed in *pink1* (*pink1*^*B9*^) and *parkin* (*park*^25^) mutant flies. The term 'young\' corresponds to heads from 3-day-old *pink1* and *parkin* mutant flies and 'aged\' to heads from 21- and 30-day-old *parkin* and *pink1* mutant flies, respectively. The activation *z*-scores for ATF4 and TRIB3 are indicated. Red and blue correspond to significant positive (*z* ⩾2) and negative (*z* ⩽ −2) scores, respectively. Target molecules labelled in red correspond to positive transcripts regulated in the analysed data sets. (**d**) Changes in amino-acid abundance upon the loss of *pink1* or *parkin* function. Relative levels to the *w*^*1118*^ control flies are indicated. Red and blue correspond to metabolites that are upregulated and downregulated to a significant level, respectively. ND corresponds to an amino-acid below detection threshold. Significance was determined using Welch\'s two-sample *t*-test (*n*=8). (**e**) Analysis of dAtf4 protein levels. Whole-fly lysates were analysed by western blotting using the indicated antibodies. The first two lanes correspond to a control for the specificity of the anti-dAtf4 antibody performed by analysing the levels of overexpressed dAtf4 in transgenic flies (da \> UAS dAtf4). Genotypes: da\>+, *da*Gal4 \> + da \> UASdAtf4, *da*Gal4 \> UAS*dAtf4*; control, *w*^*1118*^](cdd2016158f1){#fig1}

![ATF4 regulates the expression of *Shmt2* and *Nmdmc*. (**a**) *In silico* identification of *SHMT2* and *NMDMC* (red) as direct downstream transcriptional targets of *ATF4*. ATF4 could be directly connected to SHMT2 and NMDMC using the 'Grow tool\' in IPA. The other one-carbon metabolism genes, *CG3999* (GCS P protein, glycine dehydrogenase) and *CG6415* (GCS T protein, aminomethyl transferase) (green), found to be upregulated in the heads of *pink1* or *parkin* mutant flies are also shown. A schematic diagram of metabolites related to these enzymes is also shown. (**b**) *dATF4* RNAi flies show a downregulation of mitochondrial *Shmt2* and *Nmdmc* (mean±S.D.; asterisks, one-way ANOVA with Bonferroni\'s multiple comparison test). Genotypes: Control: *elavGAL4*, all RNAi were driven by *elav*GAL4. (**c** and **d**) Increased levels of ATF4 following toxin-induced ER or mitochondrial stress. SH-SY5Y cells were incubated for 8 h in the presence of the indicated concentrations of the ER stressor thapsigargin (**c**) or the complex I inhibitor rotenone (**d**). Cell lysates were analysed using the indicated antibodies. (**e** and **f**) Transcriptional upregulation of *SHMT2*, *NMDMC* and *CHOP* following ER or mitochondrial stress (mean±S.D.; asterisks, one-way ANOVA with Bonferroni\'s multiple comparison test). SH-SY5Y cells were incubated for 8 h in the presence of the indicated concentrations of thapsigargin (Tg) (**e**) or rotenone (Rot) (**f**). (**g**) Downregulation of *ATF4* in SH-SY5Y cells. The fold change of the indicated transcript levels compared with control siRNA is indicated (mean±S.D.; asterisks, one-tailed unpaired *t*-test relative to control). (**h** and **i**) The siRNA-mediated downregulation of *ATF4* blocks the toxin-induced transcriptional upregulation of *SHMT2* and *NMDMC*. Analysis of *SHMT2* and *NMDMC* transcript levels in *ATF4* RNAi cells following toxin treatment. SH-SY5Y cells were incubated for 8 h in the presence of the indicated concentrations of thapsigargin (Tg) (**h**) or rotenone (Rot) (**i**) (mean±S.D., *n*=3; asterisks, one-way ANOVA for the siRNA variable with Bonferroni\'s multiple comparison test, *P*-value for the siRNA-drug interaction two-way ANOVA is also indicated)](cdd2016158f2){#fig2}

![*In vivo* suppression of *Shmt2* or *Nmdmc* affects development and causes motor impairment in adult flies. (**a**) RNAi-mediated suppression of *Shmt2* or *Nmdmc*. Expression levels were measured by real-time qPCR (mean±S.D.). The significant values relative to the control are indicated (asterisks, two-tailed unpaired *t*-test compared with Control). (**b**) Eclosion defects following RNAi-mediated suppression of *Shmt2* or *Nmdmc* (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**c**) Motor impairment upon RNAi-mediated suppression of *Shmt2* or *Nmdmc*. Flies were tested using a standard climbing assay (mean±S.D.; asterisks, one-way ANOVA with Dunnett\'s multiple comparison test). (**d**) Decreased lifespan upon RNAi-mediated suppression of *Shmt2* or *Nmdmc*. Fly viability was scored over a period of 90 days (*n*=165 for Control (left panel), *n*=68 for Shmt2 RNAi\#1, *n*=108 for Shmt2 RNAi\#2, *n*=143 for Control (right panel), *n*=116 for Nmdmc RNAi\#1, *n*=102 for Nmdmc RNAi\#2; asterisks, log-rank, Mantel-Cox test). (**e**) Coordinated changes in metabolite abundance on the downregulation of *Shmt2* or *Nmdmc*. Canonical pathways altered in both *Shmt2* and *Nmdmc* RNAi flies were analysed using the IPA Comparison Analysis tool. The heat map corresponds to the --log (*P*-value) for the canonical pathways significantly perturbed by the downregulation of either *Shmt2* or *Nmdmc* (cutoff for *P*-value is 0.001 for both *Shmt2* and *Nmdmc* RNAi data sets). Genotypes in (**a--e**): Control: *daGAL4*. All RNAi lines were driven by *da*GAL4](cdd2016158f3){#fig3}

![Suppression of *Shmt2* or *Nmdmc* causes mitochondrial defects. (**a** and **b**) RNAi-mediated suppression of *Shmt2* or *Nmdmc* results in mitochondrial fragmentation. (**a**) Confocal analysis of mitoGFP in the indicated larval tissues. (**b**) The quantification of mitochondrial length from larval nerve is indicated (mean±S.D., *P-*value, one-way ANOVA with Bonferroni\'s multiple comparison test). (**c**) Representative confocal image of a whole mounted control brain showing neurons loaded with TMRM. (**d**) Loss of Δψm following RNAi-mediated suppression of *Shmt2* or *Nmdmc*. The data are shown as the mean±S.D. (asterisks, one-way ANOVA with Bonferroni\'s multiple comparison test). (**e**) Loss of mitochondrial proteins in *Shmt2* and *Nmdmc* RNAi flies. Whole-fly lysates from 3-day-old flies were analysed by western blot analysis using the indicated antibodies. (**f**) Abnormal wing posture following RNAi-mediated suppression of *Nmdmc* (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**g**) The knockdown of *Nmdmc* causes mitochondrial cristae fragmentation. Ultrastructural analysis of the indirect flight muscles in *Nmdmc* RNAi flies (my, myofibrils; m, mitochondria; yellow outlines, mitochondria). Percentages of indirect-flight-muscle mitochondria exhibiting fragmented cristae normalized to area are presented (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). Genotype in (**a** and **b**): Control: *elavGAL4\>mitoGFP*; Shmt2 RNAi \#1: *elavGAL4\>mitoGFP, Shmt2 RNAi \#1*; Nmdmc RNAi \#1: *elavGAL4\>mitoGFP, Nmdmc RNAi \#1*, (**c** and **d**): Control: *elavGAL4*. All RNAi lines were driven by *elav*GAL4, (**e--g**): Control: *daGAL4*. All RNAi lines were driven by *da*GAL4](cdd2016158f4){#fig4}

![Suppressing the upregulation of *Shmt2* or *Nmdmc* deteriorates the phenotype of *pink1* or *parkin* mutants. (**a**) RNAi-mediated suppression of *dAtf4* enhances lethality in *parkin* and *pink1* mutants (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**b**) RNAi-mediated suppression of *dAtf4* in *pink1* or *parkin* mutants. Expression levels were measured by real-time qPCR (mean±S.D.). The significance is indicated (asterisks, two-tailed unpaired *t*-test). (**c**) Representative images of normal and defective thorax in *pink1* mutant, arrow points to a thoracic defect. (**d**) Enhancement of the thoracic defects in *pink1* or *parkin* mutants by RNAi-mediated suppression of *dAtf4* (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**e**) Enhancement of the motor impairment of *pink1* mutants by RNAi-mediated suppression of *dAtf4*. Flies were tested using a standard climbing assay (mean±S.D.; asterisks, one-way ANOVA with Bonferroni\'s multiple comparison test). (**f** and **g**) RNAi-mediated suppression of *dAtf4* in *pink1* or *parkin* mutants affects the transcript levels of *Shmt2* (**f**) and *Nmdmc* (**g**). Expression levels were measured by real-time qPCR (mean±S.D.). The significance is indicated (*P-*value, two-tailed unpaired *t*-test compared with *pink1B9* or *park25*). (**h**) RNAi-mediated suppression of *Shmt2* or *Nmdmc* enhances lethality in *parkin* mutants (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**i**) RNAi-mediated suppression of *Shmt2* or *Nmdmc* in *pink1* mutants. Expression levels were measured by real-time qPCR (mean±S.D.). The significant values relative to the control are indicated (asterisks, two-tailed unpaired *t*-test compared with Control). (**j**) RNAi-mediated suppression of *Shmt2* or *Nmdmc* enhances lethality in *pink1* mutants (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**k**) Enhancement of the thoracic defects of *pink1* mutants by RNAi-mediated suppression of *Shmt2* or *Nmdmc* (asterisks, *χ*^2^ two-tailed, 95% confidence intervals). (**l**) Enhancement of the motor impairment of *pink1* mutants by RNAi-mediated suppression of *Nmdmc*. Flies were tested using a standard climbing assay (mean±S.D.; asterisks, one-way ANOVA with Bonferroni\'s multiple comparison test). Genotypes in (**a** and **b** and **d--l**): Control: *daGAL4*; park25: *park*^*25*^*, daGAL4/park*^*25*^; pink1B9: *pink1*^*B9*^*, daGAL4*. All RNAi lines were driven by *da*GAL4. (**c**): Control: *w*^*1118*^](cdd2016158f5){#fig5}

![Neuronal loss in *pink1* and *parkin* mutants is complemented by *Shmt2* or *Nmdmc*. (**a**) Analysis of *Shmt2* and *Nmdmc* expression levels (mean±S.D.; asterisks, two-tailed unpaired *t*-test relative to control). (**b**) Analysis of Shmt2 and Nmdmc protein levels. Whole-fly lysates were analysed using western blotting with the indicated antibodies. The 3-day-old flies were used for analysis of transcript and protein levels. (**c**) Expression of *Shmt2* or *Nmdmc* rescues the loss of Δψm (mean±S.D.; asterisks, one-way ANOVA with Dunnett\'s multiple comparison test). (**d**) A whole mounted control fly brain showing TH-positive neurons, arrows indicate individual PPL1 cluster neurons. (**e**) Schematic diagram of a fly brain in sagittal orientation indicating the PPL1 cluster of dopaminergic neurons in yellow. (**f**) Expression of *Shmt2* or *Nmdmc* rescues the loss of dopaminergic neurons in the PPL1 cluster of *pink1* and *parkin* mutant flies (mean±S.D.; asterisks, one-way ANOVA with Dunnett\'s multiple comparison test). (**g**) RNAi-mediated suppression of *dGcn2* fails to rescue the loss of dopaminergic neurons in the PPL1 cluster of *pink1* or *parkin* mutant flies (mean±S.D.; asterisks, one-way ANOVA with Dunnett\'s multiple comparison test). Genotypes in (**a** and **b**): Control: *daGAL4*, *Shmt2* and *Nmdmc* transgenes were driven by *da*GAL4, (**c--g**): Control: *elavGAL4*, *Shmt2* and *Nmdmc* transgenes and RNAi *dGcn2* were driven by *elav*GAL4](cdd2016158f6){#fig6}
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